Neuropsychiatric disorders affect millions of people worldwide. Despite advances in research, current diagnostic and drug development approaches lack precision, delaying effective treatments and personalized medicine solutions. There is a critical need for human-relevant models that allow for a deeper understanding of disease mechanisms and a more accurate prediction of therapeutic outcomes.

At Engram-Edge, we tackle this challenge by using advanced 3D human brain models that mimic key structural and functional aspects of the human brain, offering a cutting-edge platform for studying neuropsychiatric diseases, testing potential therapies, and advancing personalized medicine.

Our mission is to revolutionize the way we diagnose, understand, and treat disorders of the nervous system.